Virtus ETF Advisers »

Alnylam Pharmaceuticals Inc Note 1.000 9/1 shares owned by Virtus ETF Advisers

Quarter-by-quarter ownership of Alnylam Pharmaceuticals Inc Note 1.000 9/1 shares owned by Virtus ETF Advisers from 13F filings

Historical chart of Virtus ETF Advisers investment in Alnylam Pharmaceuticals Inc Note 1.000 9/1

Tip: Access up to 7 years of quarterly data

All positions including Alnylam Pharmaceuticals Inc Note 1.000 9/1 held by Virtus ETF Advisers consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Alnylam Pharmaceuticals Inc Note 1.000 9/1 by Virtus ETF Advisers

Quarter filed Position value Share count Share price at filing
2025-09-30 $77k 47k 1.64
2025-06-30 $61k 47k 1.30
2025-03-31 $54k 47k 1.15

More positions owned by Virtus ETF Advisers

Ssr Mining (SSRM)
Icici Bank Adr (IBN)
Weibo Corp Sponsored Adr (WB)
Hdfc Bank Sponsored Ads (HDB)
Centerra Gold (CGAU)
Primoris Services (PRIM)
Ishares Tr Msci India Etf (INDA)
Grupo Cibest Sa Spon Ads (CIB)
Norwegian Cruise Line Hldg L SHS (NCLH)
Phibro Animal Health Corp Cl A Com (PAHC)
CommVault Systems (CVLT)
Globe Life (GL)
Nmi Hldgs Inc cl a (NMIH)
Ambarella SHS (AMBA)
Penguin Solutions (PENG)

View all positions for Virtus ETF Advisers

Top funds holding Alnylam Pharmaceuticals Inc Note 1.000 9/1

Ing Investment Management
Bnp Paribas Arbitrage, Snc
State Street Corporation
Manufacturers Life Insurance Company
FMR
MacKay Shields
LMR Partners
Parallax Volatility Advisers
Morgan Stanley
BlackRock
Lord, Abbett & Co
Universal- Beteiligungs- und Servicegesellschaft mbH
SSI Investment Management
Jpmorgan Chase & Co
Nicholas Investments Partners

View all funds holding Alnylam Pharmaceuticals Inc Note 1.000 9/1